Nan Jin

Nanjing, 210095, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Earthworm effects on plant growth-defence relationships covary with rhizosphere multitrophic associations under low nitrogen availability.

Earthworm effects on plant growth-defence relationships covary with rhizosphere multitrophic associations under low nitrogen availability.

Journal: Proceedings. Biological sciences

Published: May 19, 2026

Combined treatment of inetetamab plus pyrotinib and vinorelbine in managing advanced HER2-positive breast cancer patients (ILLUMINE): a multicenter, retrospective, real-world study.

Combined treatment of inetetamab plus pyrotinib and vinorelbine in managing advanced HER2-positive breast cancer patients (ILLUMINE): a multicenter, retrospective, real-world study.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: March 10, 2025

An open-label phase II study: The efficiency and safety of anlotinib + eribulin in patients with HER2-negative metastatic breast cancer.

An open-label phase II study: The efficiency and safety of anlotinib + eribulin in patients with HER2-negative metastatic breast cancer.

Journal: International journal of cancer

Published: February 18, 2025

Stratified endocrine therapy for advanced breast cancer: stratification guided, combination preferred

Stratified endocrine therapy for advanced breast cancer: stratification guided, combination preferred

Journal: Zhonghua yi xue za zhi

Published: September 07, 2023

Tyrosine kinase inhibitors in HER2-positive metastatic breast cancer with trastuzumab emtansine resistance: insights from a multicenter retrospective real-world study.

Tyrosine kinase inhibitors in HER2-positive metastatic breast cancer with trastuzumab emtansine resistance: insights from a multicenter retrospective real-world study.

Journal: MedComm

Published: August 24, 2023

Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China.

Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China.

Journal: Cancers

Published: July 15, 2023

Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial.

Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial.

Journal: Cancer pathogenesis and therapy

Published: May 30, 2023

Anlotinib for the Treatment of Multiple Recurrent Lumbar and Sacral Cord Hemangioblastomas: A Case Report.

Anlotinib for the Treatment of Multiple Recurrent Lumbar and Sacral Cord Hemangioblastomas: A Case Report.

Journal: Frontiers in oncology

Published: January 21, 2022

A high-throughput microfluidic diploid yeast long-term culturing (DYLC) chip capable of bud reorientation and concerted daughter dissection for replicative lifespan determination.

A high-throughput microfluidic diploid yeast long-term culturing (DYLC) chip capable of bud reorientation and concerted daughter dissection for replicative lifespan determination.

Journal: Journal of nanobiotechnology

Published: November 06, 2021

Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study.

Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study.

Journal: Therapeutic advances in medical oncology

Published: July 22, 2021

Macroautophagy supports Sonic Hedgehog signaling by promoting Patched1 degradation.

Macroautophagy supports Sonic Hedgehog signaling by promoting Patched1 degradation.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: April 19, 2021

Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.

Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.

Journal: Oncotarget

Published: June 29, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026